Cargando…
Multiple Primary Lung Cancers: A New Challenge in the Era of Precision Medicine
With the widespread implementation of lung cancer screening, more and more patients are being diagnosed with multiple primary lung cancers (MPLCs). In the era of precision medicine, many controversies remain in differentiating MPLCs from intrapulmonary metastasis and the optimum treatment choice, es...
Autores principales: | Zhao, Lishu, Liu, Chaoyuan, Xie, Guiyuan, Wu, Fang, Hu, Chunhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585808/ https://www.ncbi.nlm.nih.gov/pubmed/33116891 http://dx.doi.org/10.2147/CMAR.S268081 |
Ejemplares similares
-
Precision Medicine: The new era in medicine
por: Twilt, Marinka
Publicado: (2016) -
Policy Challenges for Organ Allocation in an Era of “Precision Medicine”
por: Caulfield, Timothy, et al.
Publicado: (2020) -
Cystic Fibrosis Lung Disease Modifiers and Their Relevance in the New Era of Precision Medicine
por: Sepahzad, Afsoon, et al.
Publicado: (2021) -
Proteomics promises a new era of precision cancer medicine
por: Wu, Chong, et al.
Publicado: (2019) -
Using Artificial Intelligence (Watson for Oncology) for Treatment Recommendations Amongst Chinese Patients with Lung Cancer: Feasibility Study
por: Liu, Chaoyuan, et al.
Publicado: (2018)